Phototherapy Market Growing While Psoriasis Drug Market Declines, Reports National Biological Corporation
BEACHWOOD, Ohio--(BUSINESS WIRE)--Jan 6, 2021--
While the global market for psoriasis drugs has declined 11% due to the recent COVID-19 Pandemic, the demand for phototherapy devices has grown substantially. 1 This recent shift is due to lockdown measures and the ongoing safety of patients and medical staff.
“We are seeing double-digit growth in demand for our products,” shared Haley White, Chief Commercial Officer for National Biological Corporation.
Historically patients have turned to phototherapy because it costs less than biologics and is effective or more effective in treatment. According to a JAMA Dermatology study, a biologic prescription costs up to $25,000 annually to maintain. In contrast, a phototherapy device costs up to $6,000 and can be utilized for years. 2
With COVID-19, the American Academy of Dermatology has issued new guidelines for the use of biologics due to growing concerns about the effects of those drugs on the immune system. In some instances, the AAD recommends postponing or discontinuing prescription treatment altogether. 3
More than 8 million Americans are affected by psoriasis. 4 Phototherapy, also known as light therapy, treats psoriasis by slowing the rate of skin cell production safely through exposure to the use of ultraviolet light. Patients can seek phototherapy treatment at a clinic or in the comfort of their home. Treatment requires a doctor’s prescription. 5
About National Biological Corporation
National Biological Corporation, located in Beachwood, OH, manufactures home phototherapy equipment to treat psoriasis, vitiligo, and other skin conditions. For more information, go to www.natbiocorp.com or call 800-338-5045.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210106005289/en/
CONTACT: Haley White
KEYWORD: OHIO UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH OTHER SCIENCE GENERAL HEALTH RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: National Biological Corporation
Copyright Business Wire 2021.
PUB: 01/06/2021 10:00 AM/DISC: 01/06/2021 10:00 AM